NBIX logo

Neurocrine Biosciences, Inc. (NBIX) Cash From Investing

Annual CFI:

-$126.80M+$340.30M(+72.85%)
December 31, 2024

Summary

  • As of today, NBIX annual cash from investing is -$126.80 million, with the most recent change of +$340.30 million (+72.85%) on December 31, 2024.
  • During the last 3 years, NBIX annual cash from investing has risen by +$3.40 million (+2.61%).
  • NBIX annual cash from investing is now -205.42% below its all-time high of $120.28 million, reached on December 31, 2006.

Performance

NBIX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXcash flow metrics

Quarterly CFI:

-$196.70M-$167.70M(-578.28%)
September 30, 2025

Summary

  • As of today, NBIX quarterly cash from investing is -$196.70 million, with the most recent change of -$167.70 million (-578.28%) on September 30, 2025.
  • Over the past year, NBIX quarterly cash from investing has dropped by -$221.40 million (-896.36%).
  • NBIX quarterly cash from investing is now -310.60% below its all-time high of $93.40 million, reached on June 30, 2020.

Performance

NBIX Quarterly Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXcash flow metrics

TTM CFI:

-$279.80M-$221.40M(-379.11%)
September 30, 2025

Summary

  • As of today, NBIX TTM cash from investing is -$279.80 million, with the most recent change of -$221.40 million (-379.11%) on September 30, 2025.
  • Over the past year, NBIX TTM cash from investing has dropped by -$19.50 million (-7.49%).
  • NBIX TTM cash from investing is now -332.62% below its all-time high of $120.28 million, reached on December 31, 2006.

Performance

NBIX TTM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNBIXcash flow metrics

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NBIX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+72.8%-896.4%-7.5%
3Y3 Years+2.6%-220.9%-640.2%
5Y5 Years+39.9%-880.6%-1848.7%

NBIX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+72.8%-896.4%+2.5%-640.2%+41.7%
5Y5-Year-3192.7%+72.8%-411.7%+2.5%-922.9%+41.7%
All-TimeAll-Time-205.4%+72.8%-310.6%+7.7%-332.6%+41.7%

NBIX Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2025
-
-$196.70M(-578.3%)
-$279.80M(-379.1%)
Jun 2025
-
-$29.00M(-304.2%)
-$58.40M(-1.4%)
Mar 2025
-
$14.20M(+120.8%)
-$57.60M(+54.6%)
Dec 2024
-$126.80M(+72.9%)
-$68.30M(-376.5%)
-$126.80M(+51.3%)
Sep 2024
-
$24.70M(+187.6%)
-$260.30M(+31.9%)
Jun 2024
-
-$28.20M(+48.7%)
-$382.30M(+20.4%)
Mar 2024
-
-$55.00M(+72.7%)
-$480.00M(-2.8%)
Dec 2023
-$467.10M(-163.7%)
-$201.80M(-107.4%)
-$467.10M(-22.6%)
Sep 2023
-
-$97.30M(+22.7%)
-$380.90M(-10.4%)
Jun 2023
-
-$125.90M(-199.0%)
-$344.90M(-83.8%)
Mar 2023
-
-$42.10M(+63.6%)
-$187.60M(-5.9%)
Dec 2022
-$177.10M(-36.0%)
-$115.60M(-88.6%)
-$177.10M(-368.5%)
Sep 2022
-
-$61.30M(-295.2%)
-$37.80M(+63.2%)
Jun 2022
-
$31.40M(+199.4%)
-$102.70M(+54.3%)
Mar 2022
-
-$31.60M(-233.3%)
-$224.90M(-72.7%)
Dec 2021
-$130.20M(-3275.6%)
$23.70M(+118.8%)
-$130.20M(+56.8%)
Sep 2021
-
-$126.20M(-39.0%)
-$301.60M(-100.8%)
Jun 2021
-
-$90.80M(-243.9%)
-$150.20M(-541.8%)
Mar 2021
-
$63.10M(+142.7%)
$34.00M(+729.3%)
Dec 2020
$4.10M(+101.9%)
-$147.70M(-686.1%)
$4.10M(+128.6%)
Sep 2020
-
$25.20M(-73.0%)
-$14.36M(+88.5%)
Jun 2020
-
$93.40M(+181.3%)
-$125.20M(+42.8%)
Mar 2020
-
$33.20M(+120.0%)
-$218.85M(-3.7%)
Dec 2019
-$211.10M(+13.1%)
-$166.16M(-94.0%)
-$211.07M(-39.6%)
Sep 2019
-
-$85.65M(>-9900.0%)
-$151.17M(-36.7%)
Jun 2019
-
-$243.00K(-100.6%)
-$110.62M(+23.7%)
Mar 2019
-
$40.97M(+138.6%)
-$144.89M(+40.4%)
Dec 2018
-$242.90M(+3.3%)
-$106.26M(-135.6%)
-$242.91M(-24.1%)
Sep 2018
-
-$45.09M(-30.7%)
-$195.67M(-5.2%)
Jun 2018
-
-$34.51M(+39.5%)
-$185.97M(+49.0%)
Mar 2018
-
-$57.05M(+3.3%)
-$364.57M(-45.3%)
Dec 2017
-$251.25M(-322.4%)
-$59.01M(-66.7%)
-$250.87M(-41.9%)
Sep 2017
-
-$35.39M(+83.4%)
-$176.79M(-80.0%)
Jun 2017
-
-$213.11M(-476.2%)
-$98.20M(-198.9%)
Mar 2017
-
$56.65M(+275.9%)
$99.25M(-12.1%)
Dec 2016
$112.95M(+157.7%)
$15.07M(-65.1%)
$112.86M(-5.8%)
Sep 2016
-
$43.20M(+375.9%)
$119.81M(+316.7%)
Jun 2016
-
-$15.66M(-122.3%)
$28.75M(+402.5%)
Mar 2016
-
$70.25M(+219.2%)
-$9.51M(+95.1%)
Dec 2015
-$195.81M(-85.8%)
$22.01M(+146.0%)
-$195.85M(+3.2%)
Sep 2015
-
-$47.86M(+11.2%)
-$202.32M(-33.8%)
Jun 2015
-
-$53.91M(+53.6%)
-$151.25M(+2.9%)
Mar 2015
-
-$116.09M(-846.8%)
-$155.73M(-47.8%)
Dec 2014
-$105.37M(-2073.1%)
$15.54M(+383.4%)
-$105.37M(-5.2%)
Sep 2014
-
$3.22M(+105.5%)
-$100.18M(+4.3%)
Jun 2014
-
-$58.40M(+11.2%)
-$104.70M(-313.6%)
Mar 2014
-
-$65.73M(-417.1%)
-$25.31M(-574.0%)
Dec 2013
$5.34M(+115.4%)
$20.73M(+1688.4%)
$5.34M(-57.3%)
Sep 2013
-
-$1.30M(-106.2%)
$12.50M(-48.9%)
Jun 2013
-
$20.99M(+159.8%)
$24.46M(+199.3%)
Mar 2013
-
-$35.08M(-225.8%)
-$24.62M(+29.2%)
Dec 2012
-$34.76M(-884.2%)
$27.89M(+161.7%)
-$34.76M(+44.9%)
Sep 2012
-
$10.65M(+137.9%)
-$63.12M(-12.9%)
Jun 2012
-
-$28.09M(+37.9%)
-$55.91M(-102.4%)
Mar 2012
-
-$45.22M(-9561.5%)
-$27.63M(-678.5%)
Dec 2011
-$3.53M(+93.5%)
-$468.00K(-102.6%)
-$3.55M(+61.2%)
Sep 2011
-
$17.86M(+9154.4%)
-$9.16M(+83.4%)
Jun 2011
-
$193.00K(+100.9%)
-$55.07M(+32.5%)
Mar 2011
-
-$21.14M(-247.9%)
-$81.56M(-49.1%)
DateAnnualQuarterlyTTM
Dec 2010
-$54.70M(-553.7%)
-$6.08M(+78.3%)
-$54.70M(-28.6%)
Sep 2010
-
-$28.05M(-6.7%)
-$42.54M(-536.1%)
Jun 2010
-
-$26.30M(-559.5%)
-$6.69M(-133.1%)
Mar 2010
-
$5.72M(-5.9%)
$20.19M(+67.5%)
Dec 2009
$12.06M(-72.9%)
$6.09M(-22.0%)
$12.06M(+10.7%)
Sep 2009
-
$7.80M(+1242.9%)
$10.89M(+72.4%)
Jun 2009
-
$581.00K(+124.1%)
$6.31M(+16.6%)
Mar 2009
-
-$2.41M(-149.1%)
$5.41M(-87.8%)
Dec 2008
$44.42M(+113.2%)
$4.92M(+52.2%)
$44.43M(+34.9%)
Sep 2008
-
$3.23M(+1109.1%)
$32.93M(-35.6%)
Jun 2008
-
-$320.00K(-100.9%)
$51.14M(+16.4%)
Mar 2008
-
$36.60M(+656.4%)
$43.95M(+110.9%)
Dec 2007
$20.84M(-82.7%)
-$6.58M(-130.7%)
$20.84M(-58.8%)
Sep 2007
-
$21.44M(+385.1%)
$50.58M(-6.1%)
Jun 2007
-
-$7.52M(-155.7%)
$53.89M(-27.5%)
Mar 2007
-
$13.49M(-41.7%)
$74.33M(-38.2%)
Dec 2006
$120.28M(+1182.0%)
$23.16M(-6.4%)
$120.28M(+37.8%)
Sep 2006
-
$24.75M(+91.5%)
$87.31M(+119.1%)
Jun 2006
-
$12.93M(-78.3%)
$39.85M(-31.7%)
Mar 2006
-
$59.44M(+706.4%)
$58.38M(+522.2%)
Dec 2005
$9.38M(-49.2%)
-$9.80M(+56.8%)
$9.38M(-62.9%)
Sep 2005
-
-$22.72M(-172.2%)
$25.31M(-76.1%)
Jun 2005
-
$31.46M(+201.2%)
$105.70M(+26.9%)
Mar 2005
-
$10.44M(+70.4%)
$83.31M(+351.1%)
Dec 2004
$18.47M(+109.9%)
$6.13M(-89.4%)
$18.47M(+198.4%)
Sep 2004
-
$57.67M(+536.1%)
-$18.77M(+89.0%)
Jun 2004
-
$9.07M(+116.7%)
-$170.26M(+14.0%)
Mar 2004
-
-$54.40M(-74.9%)
-$197.91M(-6.0%)
Dec 2003
-$186.65M(-305.6%)
-$31.11M(+66.8%)
-$186.65M(-35.4%)
Sep 2003
-
-$93.81M(-404.7%)
-$137.81M(-518.4%)
Jun 2003
-
-$18.59M(+56.9%)
-$22.28M(-297.2%)
Mar 2003
-
-$43.13M(-343.4%)
$11.30M(+124.6%)
Dec 2002
-$46.02M(-176.6%)
$17.72M(-18.4%)
-$46.02M(+49.4%)
Sep 2002
-
$21.72M(+44.8%)
-$90.89M(+27.1%)
Jun 2002
-
$14.99M(+114.9%)
-$124.66M(+5.0%)
Mar 2002
-
-$100.45M(-269.9%)
-$131.16M(-688.4%)
Dec 2001
-$16.64M(+78.0%)
-$27.16M(-125.5%)
-$16.64M(+74.4%)
Sep 2001
-
-$12.04M(-241.8%)
-$65.10M(-48.8%)
Jun 2001
-
$8.49M(-39.6%)
-$43.75M(+17.6%)
Mar 2001
-
$14.07M(+118.6%)
-$53.07M(+29.9%)
Dec 2000
-$75.67M(-257.0%)
-$75.62M(-912.0%)
-$75.67M(-159.5%)
Sep 2000
-
$9.31M(+1222.0%)
-$29.16M(+25.5%)
Jun 2000
-
-$830.00K(+90.3%)
-$39.16M(-38.1%)
Mar 2000
-
-$8.54M(+70.7%)
-$28.35M(-33.6%)
Dec 1999
-$21.20M(-551.1%)
-$29.11M(-4181.0%)
-$21.23M(-652.6%)
Sep 1999
-
-$680.00K(-106.8%)
$3.84M(-62.3%)
Jun 1999
-
$9.97M(+806.9%)
$10.18M(+1285.8%)
Mar 1999
-
-$1.41M(+65.1%)
-$858.30K(-118.2%)
Dec 1998
$4.70M(+165.3%)
-$4.04M(-171.5%)
$4.71M(+652.2%)
Sep 1998
-
$5.66M(+633.2%)
-$852.00K(+95.6%)
Jun 1998
-
-$1.06M(-125.5%)
-$19.51M(-665.1%)
Mar 1998
-
$4.15M(+143.3%)
$3.45M(+147.9%)
Dec 1997
-$7.20M(+85.2%)
-$9.60M(+26.2%)
-$7.20M(-118.2%)
Sep 1997
-
-$13.00M(-159.4%)
-$3.30M(+17.5%)
Jun 1997
-
$21.90M(+436.9%)
-$4.00M(+91.4%)
Mar 1997
-
-$6.50M(-14.0%)
-$46.60M(+4.1%)
Dec 1996
-$48.60M
-$5.70M(+58.4%)
-$48.60M(-13.3%)
Sep 1996
-
-$13.70M(+33.8%)
-$42.90M(-46.9%)
Jun 1996
-
-$20.70M(-143.5%)
-$29.20M(-243.5%)
Mar 1996
-
-$8.50M
-$8.50M

FAQ

  • What is Neurocrine Biosciences, Inc. annual cash from investing?
  • What is the all-time high annual cash from investing for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. annual cash from investing year-on-year change?
  • What is Neurocrine Biosciences, Inc. quarterly cash from investing?
  • What is the all-time high quarterly cash from investing for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. quarterly cash from investing year-on-year change?
  • What is Neurocrine Biosciences, Inc. TTM cash from investing?
  • What is the all-time high TTM cash from investing for Neurocrine Biosciences, Inc.?
  • What is Neurocrine Biosciences, Inc. TTM cash from investing year-on-year change?

What is Neurocrine Biosciences, Inc. annual cash from investing?

The current annual cash from investing of NBIX is -$126.80M

What is the all-time high annual cash from investing for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high annual cash from investing is $120.28M

What is Neurocrine Biosciences, Inc. annual cash from investing year-on-year change?

Over the past year, NBIX annual cash from investing has changed by +$340.30M (+72.85%)

What is Neurocrine Biosciences, Inc. quarterly cash from investing?

The current quarterly cash from investing of NBIX is -$196.70M

What is the all-time high quarterly cash from investing for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high quarterly cash from investing is $93.40M

What is Neurocrine Biosciences, Inc. quarterly cash from investing year-on-year change?

Over the past year, NBIX quarterly cash from investing has changed by -$221.40M (-896.36%)

What is Neurocrine Biosciences, Inc. TTM cash from investing?

The current TTM cash from investing of NBIX is -$279.80M

What is the all-time high TTM cash from investing for Neurocrine Biosciences, Inc.?

Neurocrine Biosciences, Inc. all-time high TTM cash from investing is $120.28M

What is Neurocrine Biosciences, Inc. TTM cash from investing year-on-year change?

Over the past year, NBIX TTM cash from investing has changed by -$19.50M (-7.49%)
On this page